Navigation Links
Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,,,Associated With Insertion of an Intravenous Catheter in Their Phase,,,2 Clinical Trial

Iontophoretic Drug Delivery System, dermal patch and a direct current power source with lidocaine and epinephrine (IDDS)

SEATTLE, March 20, 2007 /PRNewswire/ -- Dharma Therapeutics, Inc., ("Dharma") Seattle, WA, a transdermal drug delivery company and wholly owned subsidiary of Transcutaneous Technologies, Inc. ("TTI"), Tokyo, Japan announced that its active transdermal delivery technology, which administers lidocaine and epinephrine through the skin via a mild electric current, was safe and effective in delivering topical anesthesia in 8 minutes.

About the trial:

The trial was a Phase 2, double-blind, randomized, placebo-controlled, two-arm study evaluating the safety and effectiveness of the administration of lidocaine and epinephrine using the IDDS to provide topical anesthesia in adults undergoing a venipuncture procedure. Seventy one (71) healthy volunteer subjects ranging in age from 18 to 57 years old were treated at a single clinical site. Subjects were randomized to receive an 8 minute administration of lidocaine plus epinephrine (Treatment Arm) or epinephrine alone (Placebo-Control Arm) at the site of insertion of an intravenous catheter into the posterior surface of the subject's hand. After placement of the intravenous catheter, subjects evaluated their pain using the VAS scoring system and were asked if they would use the IDDS again. Investigators also evaluated the subjects' level of pain and whether or not IDDS treatment was acceptable to the subjects. Safety of the treatment was also monitored.

Results:

Median VAS scores were reduced by 58%, a highly significant reduction in perceived pain (p < / = 0.01). The majority of subjects in the Treatment Arm reported elimination of their pain, while only a minority of subjects in the Placebo-Control Arm reported pain elimination (p < 0.05). Thirty-four of thirty-si
'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:8/26/2014)... 26, 2014 Using publicly released 2015 rate ... costs for five common specialty drugs. Specialty drugs ... their high costs and shortage of generic alternatives. ... per prescription, and are used for a broad ... sclerosis. HealthPocket found that among ...
(Date:8/26/2014)... SAN DIEGO , Aug. 26, 2014 /PRNewswire/ ... Sorrento), a late-stage clinical oncology company developing new ... announced that it has received funding to advance ... the potential treatment of IPF, which affects more ... in the lungs increases and patients gradually lose ...
(Date:8/26/2014)... LONDON , August 26, 2014 ... http://www.fdna.com ) and London Medical Databases Ltd. ( http://www.lmdatabases.com ... for the first time, online access to the award ... developer of the Facial Dysmorphology Novel Analysis ... [ TM ] , the only available ...
Breaking Medicine Technology:2015 Platinum Plans Are Best Buy for Consumers Using Expensive Specialty Drugs 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3
... Perrigo Company (Nasdaq: PRGO; TASE) today announced that ... all of the assets of Paddock Laboratories, Inc. ("Paddock"), ... products for approximately $540 million in cash. Perrigo expects ... of the acquisition of Paddock,s assets. The net present ...
... Reportlinker.com announces that a new market research ... Hospital Angiography Census ... comprehensive European market report on the installed base ... Angiography, CT, MRI,) and radiology IT systems (PACS, ...
Cached Medicine Technology:Perrigo to Acquire Assets of Paddock Labs for $540 Million 2Perrigo to Acquire Assets of Paddock Labs for $540 Million 3Perrigo to Acquire Assets of Paddock Labs for $540 Million 4Perrigo to Acquire Assets of Paddock Labs for $540 Million 5Reportlinker Adds Hospital Angiography Census 2Reportlinker Adds Hospital Angiography Census 3
(Date:8/27/2014)... StartX , a nonprofit technology accelerator ... a pioneering institute driving biotechnology innovation at the University ... laboratory customized for the needs of early stage medical ... lab space, named “StartX-QB3 Labs,” is the first research ... Care focused on developing entrepreneurs from academia to industry. ...
(Date:8/27/2014)... NY (PRWEB) August 27, 2014 For ... a new face on plastic surgery when triple-board certified, ... art – figurative clay sculptures he has created from ... precision, authority and artistry at a unique event on ... Space located at 23 Warren Street. The “faces” who ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Humility of ... program at St. Elizabeth Boardman Health Center in Boardman ... Mall in Niles beginning Sept. 8. , SlimDown teaches ... with regard to food, physical activity and behavior. , ... St. Elizabeth Boardman Health Center and Mondays at St. ...
(Date:8/27/2014)... 27, 2014 Two of Woodland Hills’ ... Jivraj of the Anacapa Dental Art Institute, deal with serious ... complex oral surgery. , So patients can be reluctant to ... sores left from biting their lip or gums. , “The ... by the accidental bite,” Dr. Reshad said. “This canker or ...
(Date:8/27/2014)... 2014 A recent news article in ... list of “Five tips for relieving dry skin.” Sharon ... Kleyne Hour Power of Water radio show describes the ... tips that are seldom reported but which, Kleyne believes, ... Sharon Kleyne is Founder of Bio Logic Aqua Research, ...
Breaking Medicine News(10 mins):Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 2Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 3Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 4Health News:Presenting A Remarkable Fusion of Art, Fashion and Plastic Surgery 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 2Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 3Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 4Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 5Health News:Water Advocate Sharon Kleyne Reports New Discoveries for Relief of Dry Dehydrated Skin 2Health News:Water Advocate Sharon Kleyne Reports New Discoveries for Relief of Dry Dehydrated Skin 3
... by a Holyrood committee’s call for a public inquiry into ... NHS treatments has created ripples.// ,This was the ... reason for limited efforts to track down patients infected with ... inquiry by just one casting vote from convener Roseanna Cunningham. ...
... Journal of Preventive Medicine in its May issue has ... don’t exercise enough, which is highly recommended by the ... ,“People with arthritis are not meeting physical ... experts in the arthritis field,” said co-author Jennifer Hootman, ...
... diet and ALS saying that a ketogenic- high caloric ... (ALS). // The Mount Sinai School of Medicine is ... neuronal cell death, the cause of ALS. ,According ... which spinal and cortical motor neurons die causing relentlessly ...
... May issue of the American Journal of Preventive Medicine, researchers ... // and research on the reason as to why more ... that this was because of obesity which plays a major ... ,The researchers felt that the lifestyle interventions that can be ...
... to be effective in reducing chest pain, not associated ... pain have no identifiable cause // for their pain. ... be severely bothered by their symptom. Particularly, young women ... ,It is not known exactly what causes non-cardiac pain. ...
... was conducted by the London School of Hygiene, to access ... it was found that serious gaps in some national plans ... Italy, Latvia, Lithuania, Romania, Poland and Portugal were the least ... to plan in such a way that they need to ...
Cached Medicine News:Health News:Most People With Arthritis Do Little Or No Exercise At All 2Health News:Obesity The Major Cause Of The Increase In Newly Diagnosed Diabetes 2Health News:Non-Cardiac Chest Pain Can Be Treated By Hypnotherapy 2Health News:Joint Effort among Various Nations to Tackle Bird Flu 2
...
1.7% Tryptone, 0.3% Soytone, 0.5% Sodium Chloride, 0.25% Dextrose, 0.25% Potassium Phosphate....
... The basic Thermomixer is a compact model ... 24 x 1.5 ml tubes. Impressive features ... clear design, and high stabilityeven at maximum ... for gentle to vigorous mixing, including intermittent ...
... Penicillin/25,000 ug Streptomycin All ... and Buffer products are ... cGMP regulations and are ... assure compatibility. , Typical ...
Medicine Products: